EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Amblyopia in 2026: A State-of-the-Art Review of Multidimensional Phenotyping, Response Heterogeneity, and Clinical Considerations

Danjela Ibrahimi iD, José R García-Martínez iD

Brain Sciences · 27.04.2026 · 16 (5) · 467

DOI: 10.3390/brainsci16050467 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 27.04.2026. Verfasst von Danjela Ibrahimi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Universidad Autónoma de Querétaro, Santiago de Querétaro 76010, Mexico. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amblyopia is increasingly conceptualized as a neurodevelopmental visual disorder that often arises from discordant binocular visual experience during early life and is associated with abnormal binocular interactions, interocular suppression, orientation-dependent developmental abnormalities in selected refractive phenotypes, and experience-dependent plasticity, consistent with a distributed-network perspective rather than a purely monocular acuity deficit. We performed a structured state-of-the-art narrative synthesis of peer-reviewed reviews, randomized controlled trials, and key mechanistic human studies indexed in PubMed/MEDLINE, Web of Science, and Scopus (1 January 2016–28 February 2026; last search 28 February 2026), prioritizing recent evidence from 2021–2026. Literature supports consideration of clinically trackable constructs beyond best-corrected visual acuity (BCVA), including quantified suppression/imbalance, binocular function, and functionally meaningful outcomes such as reading-related limitation and broader functional impact. Across established and emerging intervention classes, treatment effects are heterogeneous across ages and etiologies. Evidence is strongest for conventional penalization and selected active training-based approaches, whereas newer protocol-standardized approaches remain investigational and require prospective evaluation with transparent exposure/dose reporting. Based on these findings, we outline a clinically oriented, core outcome set for amblyopia and strabismus (COSAMS)-aligned framework that combines quantified binocular imbalance with multidimensional phenotyping and a hypothesis-driven, prospectively testable therapeutic model intended to structure (not replace) clinical decision-making. Priorities for precision-oriented amblyopia care include standardization of suppression metrics, adoption of core outcome sets, transparent reporting of ‘not measurable’ outcomes and missingness, and prospective validation of phenotype-driven, prediction-ready frameworks.

Schlagwörter

Stichwörter der Autor:innen

COSAMSamblyopiabinocular functionclinical phenotypingdigital therapeuticsfunctional outcomesgraded optical penalizationinterocular suppressionorthopticsvision therapy

Autor:innen und Institutionen

  • Facultad de Medicina, Universidad Autónoma de Querétaro, Santiago de Querétaro 76010, Mexico.
  • Brain Vision & Learning Center, Misión de Capistrano 117, Juriquilla, Santiago de Querétaro 76226, Mexico.
  • Facultad de Ingeniería Mecánica y Eléctrica, Universidad Veracruzana, Poza Rica 93390, Mexico.

ORCID-Profile: Danjela Ibrahimi, José R García-Martínez

Zitieren

APA

Ibrahimi, D., & García-Martínez, J. R. (2026). Amblyopia in 2026: A State-of-the-Art Review of Multidimensional Phenotyping, Response Heterogeneity, and Clinical Considerations. Brain Sciences, 16(5), 467. https://doi.org/10.3390/brainsci16050467

Vancouver

Ibrahimi D, García-Martínez JR. Amblyopia in 2026: A State-of-the-Art Review of Multidimensional Phenotyping, Response Heterogeneity, and Clinical Considerations. Brain Sciences. 2026;16(5):467. doi:10.3390/brainsci16050467

BibTeX
@article{Ibrahimi2026,
  author = {Ibrahimi, Danjela and García-Martínez, José R},
  title = {Amblyopia in 2026: A State-of-the-Art Review of Multidimensional Phenotyping, Response Heterogeneity, and Clinical Considerations},
  journal = {Brain Sciences},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {467},
  doi = {10.3390/brainsci16050467}
}
Kostenlos starten →